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Abstract 
 Introduction: Vitamin B12 has important functions in physiology 
and pathology of human body. It can help against diseases through 
improving immune system. The role of Its deficiency with metformin 
treatment is still subjecting to diabetes. Objectives: 1. To investigate the 
prevalence of Vitamin B12 deficiency among diabetics visiting internal 
medicine clinics in Prince Rashid Hospital. 2. To explore the association of 
Vitamin B12 deficiency with metformin treatment among the same sample. 
Methods and subjects, Study design: A retrospective design was employed 
to collect data from files of diabetic patients. Study sample: A total of 447 
files of diabetic patients were accessed if inclusion criteria were met. 
Inclusion criteria: Diabetic patient. Vitamin B12 status is mentioned. 
Metformin treatment is recorded in files of diabetic patients. Data 
collection: data will be collected for each patient and entered into excel sheet 
for further analysis. Statistical analysis: SPSS version 20 was used for data 
analysis. Data was presented as frequency and percentage for numerical 
variables, whereas the association between variables was tested using Chi-
Square test. Significance was tested at alpha level < 0.05. Results: The 
prevalence of vitamin B12 deficiency was 7.2%. The mean age of study 
participants was 55.70+10.13 years. Metformin intake was reported by 
approximately 84% of diabetics. About 76% of participants had cardiac 
diseases. No significant association was observed between metformin and 
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vitamin B12 deficiency (p=0.269). Conclusion: The prevalence of vitamin 
B12 deficiency among diabetics was 7.2%. No significant association was 
observed between treating diabetics with metformin and vitamin B12 
deficiency. Recommendation: Lacking the association between treatment of 
metformin and vitamin B12 deficiency may due to small participants 
included in other studies, and we recommend to include larger numbers of 
participants in future studies. 
 
Keywords: Diabetes type 2, vitamin B12, metformin 
 
Introduction 
 Diabetes mellitus is considered a chronic disease with metabolic 
nature.  Furthermore, Type 2 diabetes has been reported to affect 
approximately 382 million persons on global level (Cho, 2013).  
 
Vitamin B12 deficiency  
 In a study by Howard et al (1998), it has been reported that the 
deficiency of vitamin b12 among elderly individuals is not due to dietary low 
supplementations, whereas other studies showed that vitamin B12 deficiency 
is due to pathological conditions that are associated with ageing (Andres et 
al.,2007; Herrmann and Obeid, 2008).  
 
Metformin and diabetes 
 According to a recent study by Niafar et al (2015), metformin is 
considered the only biguanide oral hypoglycemic drug of choice to treat 
patients with type-2 diabetes. According to American Diabetes Association 
(2014), several considerations about the use of metformin treatment 
including its efficacy, safety, and cardiovascular benefits have made it as the 
first choice to treat diabetes type 2.   
 
The effect of metformin treatment on vitamin B12 
 Niafar et al (2015) conducted a study to investigate the effect of 
metformin treatment on vitamin B12 deficiency. This study was a meta- 
analysis review. The authors came with the following conclusion: treatment 
by metformin leads to increased incidence of VB12 deficiency and reduced 
serum VB12 levels. 
 Yazdanpanah (2014) conducted a study to investigate the impacts of 
metformin on the concentration of vitamin B12 among diabetics. Patients 
were categorized into two groups: metformin treated patients group, and a 
group treated with other anti-diabetic drugs. Study findings showed that 
there was no significant differences in the level of vitamin B12 between two 
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groups.  The results did not show significant association between age and 
gender with vitamin B12.  
 According to findings of two studies, using the treatment of 
metformin leads to decreased levels of serum vitamin B12 (Wulffele et al., 
2003; Reinstatler et al., 2012). Furthermore, it has been emphasized that 
compared with diabetic patients not treated with metformin, or non-diabetics, 
treating diabetics with metformin caused lowering levels of vitamin B12 
(Reinstatler et al., 2012).  
 Two studies focusing on the evaluation of diabetics with metformin 
have shown that vitamin B 12 deficiency is in the range of 5.8 to 33 % 
(Pflipsen et al., 2009; Reinstatler et al., 2012). 
 
Study objectives  
 The main objectives of the present study were: to investigate the 
prevalence of vitamin B12 deficiency among diabetic patients, and to 
examine a proposed association between metformin treatment and vitamin 
B12 deficiency. 
 
Methods and subjects 
Study design: A retrospective design was employed to collect data from files 
of diabetic patients.  
Study sample: A total of 447 files of diabetic patients were accessed if 
inclusion criteria were met. 
 Inclusion criteria: 
- Diabetic patient. 
- Vitamin B12 status is mentioned. 
- Metformin treatment is recorded in files of diabetic patients. 
 
Data collection: data was collected for each patient and entered into excel 
sheet for further analysis. 
 
Statistical analysis: SPSS version 20 was used for data analysis. Data was 
presented as frequency and percentage for numerical variables, whereas the 
association between variables was tested using Chi-Square test. Significance 
was tested at alpha level < 0.05. 
 
Results 
 As seen in table 1, study sample included 447 patients. The mean age 
is 55.70+10.13 years. A total of 210 (47%) participants were males. The 
mean intake of metformin is 1473+937 mg/day. Family history of cardiac 
disease was shown among 280 (62.6%) of participants. About 31% of 
participants had positive history of diabetes. Metformin intake was reported 
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among 84% of participants. The prevalence of vitamin B12 deficiency 
among diabetics was 7.2%.about 76% of diabetics had cardiac diseases. 
Table 1: general characteristics of participants 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The relationship between metformin intake and study variables 
 As it can be seen in table 2, there were no significant association 
between metformin intake and other variables under study. As an example, 
metformin intake was not associated significantly with vitamin B12 
deficiency (p=0.269), gender (p=0.228), cardiac disease (p=0.315), family 
history of cardiac disease (p=0.258), and family history of diabetes 
(p=0.199). 
Table 2: The relationship between metformin intake and study variables 
Variable          Metformin  P value  
   Yes         No  
N % N % 
Vitamin B12 
- Deficiency  
- No deficiency  
 
29 
3 
 
90.6 
9.4 
 
345 
70 
 
83.1 
16.9 
0.269 
Gender  
- Male  
- Female  
 
171 
203 
 
81.4 
85.7 
 
39 
34 
 
18.6 
14.3 
0.228 
Cardiac disease 
- Yes  
- No  
 
287 
87 
 
84.7 
80.6 
 
52 
21 
 
15.3 
19.4 
0.315 
Family history of cardiac disease 
- Yes  
- No  
 
230 
50 
 
82.1 
17.9 
 
144 
23 
 
86.2 
13.8 
0.258 
Family history of diabetes 
- Yes  
- No  
 
110 
27 
 
80.3 
19.7 
 
264 
46 
 
85.2 
14.8 
0.199 
Variable   
Age (M+SD) years 55.70+10.13 
Gender (N, %) 
- Male 
- Female  
 
210 (47%) 
237 (53%) 
Metformin (M+SD) mg/day 1473+937 
Family history of CD (N, %) 
- Yes 
- No  
 
280 (62.6%) 
167 (37.4%) 
Family history of diabetes (N, %) 
- Yes  
- No  
 
137 (30.6%) 
310 (69.4%) 
Metformin intake (N, %) 
- Yes  
- No  
 
374 (83.7%) 
73 (16.3%) 
Vitamin B12 deficiency (N, %) 
- Yes  
- No  
 
32 (7.2%) 
415 (92.8%) 
Cardiac disease (N, %) 
- Yes  
- No  
 
339 (75.8%) 
108 (24.2%) 
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Discussion 
 In the present study, the prevalence of vitamin B12 deficiency among 
diabetics was 7.2%. This finding is consistent with other studies in which 
vitamin B 12 deficiency among diabetics receiving metformin was reported 
to range from 5.8 to 33 % (Pflipsen et al., 2009; Reinstatler et al., 2012). 
 We have examined the association of metformin with vitamin B12 
deficiency. Our results did not support the existence of such an association 
(p=0.269). However, the presence of significant association between the use 
of metformin and vitamin B12 deficiency is subjecting to debate in literature. 
One of the important studies in this regard is the study of Niafar et al (2015) 
who conducted a meta- analysis review and concluded that treatment by 
metformin leads to increased incidence of VB12 deficiency and reduced 
serum VB12 levels. The same findings have been confirmed by other studies 
such as the studies of Wulffele et al (2003) and Reinstatler et al (2012) in 
which it was reported that vitamin B12 deficiency was associated with the 
treatment of metformin. On the other hand, our findings agree with the study 
of Yazdanpanah (2014) who did not find a significant association between 
metformin treatment and vitamin B12 deficiency. 
 
Conclusion  
 The prevalence of vitamin B12 deficiency among diabetics was 
7.2%. No significant association was observed between treating diabetics 
with metformin and vitamin B12 deficiency. 
 
Recommendations   
 Lacking the association between treatment of metformin and vitamin 
B12 deficiency may due to small participants included in other studies, and 
we recommend to include larger numbers of participants in future studies.    
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